Net Income (Loss) Attributable to Parent in USD of Klotho Neurosciences, Inc. from Q1 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Klotho Neurosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q1 2021 to Q3 2025.
  • Klotho Neurosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2025 was -$2.9M, a 2.16% increase year-over-year.
  • Klotho Neurosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2025 was -$11.3M, a 168% decline year-over-year.
  • Klotho Neurosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$6.15M, a 769% decline from 2023.
  • Klotho Neurosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$707K, a 157% decline from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Klotho Neurosciences, Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$11.3M -$2.9M +$63.8K +2.16% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-13
Q2 2025 -$11.4M -$4.09M -$3.64M -806% Apr 1, 2025 Jun 30, 2025 10-Q 2025-11-13
Q1 2025 -$7.71M -$2.23M -$1.56M -232% Jan 1, 2025 Mar 31, 2025 10-Q 2025-11-13
Q4 2024 -$6.15M -$2.07M -$1.94M -1535% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-31
Q3 2024 -$4.21M -$2.96M -$2.82M -1954% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-13
Q2 2024 -$1.39M -$452K -$187K -70.8% Apr 1, 2024 Jun 30, 2024 10-Q 2025-11-13
Q1 2024 -$1.21M -$672K -$1.79M -160% Jan 1, 2024 Mar 31, 2024 10-Q 2025-11-13
Q4 2023 $586K -$126K -$843K -118% Oct 1, 2023 Dec 31, 2023 10-Q 2024-11-19
Q3 2023 $1.43M -$144K -$875K -120% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-19
Q2 2023 $2.3M -$264K -$55.6K -26.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 $2.36M $1.12M +$1.13M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-23
Q4 2022 $1.23M $716K Oct 1, 2022 Dec 31, 2022 10-K 2024-04-17
Q3 2022 $731K +$731K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-17
Q2 2022 -$209K -$205K -5848% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-17
Q1 2022 -$5.01K -$1.5K -42.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-17
Q3 2021 -$16* Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$3.51K Mar 16, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$3.51K Mar 16, 2021 Mar 31, 2021 10-Q 2022-05-16

Klotho Neurosciences, Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$6.15M -$5.44M -769% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 -$707K -$1.94M -157% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 $1.23M Jan 1, 2022 Dec 31, 2022 10-K 2024-04-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.